EWTX logo

Edgewise Therapeutics (EWTX) Accounts payable

annual accounts payable:

$5.58M+$1.55M(+38.61%)
December 31, 2024

Summary

  • As of today (July 6, 2025), EWTX annual accounts payable is $5.58 million, with the most recent change of +$1.55 million (+38.61%) on December 31, 2024.
  • During the last 3 years, EWTX annual accounts payable has risen by +$1.74 million (+45.17%).
  • EWTX annual accounts payable is now -8.62% below its all-time high of $6.11 million, reached on December 31, 2022.

Performance

EWTX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

quarterly accounts payable:

$8.79M+$3.21M(+57.54%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX quarterly accounts payable is $8.79 million, with the most recent change of +$3.21 million (+57.54%) on March 31, 2025.
  • Over the past year, EWTX quarterly accounts payable has increased by +$4.07 million (+86.09%).
  • EWTX quarterly accounts payable is now at all-time high.

Performance

EWTX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

EWTX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+38.6%+86.1%
3 y3 years+45.2%+64.6%
5 y5 years+736.4%-

EWTX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-8.6%+45.2%at high+210.8%
5 y5-year-8.6%+736.4%at high+456.3%
alltimeall time-8.6%+736.4%at high+456.3%

EWTX Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$8.79M(+57.5%)
Dec 2024
$5.58M(+38.6%)
$5.58M(-1.2%)
Sep 2024
-
$5.65M(-16.9%)
Jun 2024
-
$6.80M(+44.0%)
Mar 2024
-
$4.72M(+17.3%)
Dec 2023
$4.03M(-34.1%)
$4.03M(-24.3%)
Sep 2023
-
$5.32M(+40.7%)
Jun 2023
-
$3.78M(-2.4%)
Mar 2023
-
$3.88M(-36.5%)
DateAnnualQuarterly
Dec 2022
$6.11M(+58.9%)
$6.11M(+6.0%)
Sep 2022
-
$5.76M(+103.6%)
Jun 2022
-
$2.83M(-47.0%)
Mar 2022
-
$5.34M(+39.0%)
Dec 2021
$3.84M(+143.2%)
$3.84M(+67.7%)
Sep 2021
-
$2.29M(-18.6%)
Jun 2021
-
$2.82M(+73.7%)
Mar 2021
-
$1.62M(+2.6%)
Dec 2020
$1.58M(+136.9%)
$1.58M
Dec 2019
$667.00K
-

FAQ

  • What is Edgewise Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual accounts payable year-on-year change?
  • What is Edgewise Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly accounts payable year-on-year change?

What is Edgewise Therapeutics annual accounts payable?

The current annual accounts payable of EWTX is $5.58M

What is the all time high annual accounts payable for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual accounts payable is $6.11M

What is Edgewise Therapeutics annual accounts payable year-on-year change?

Over the past year, EWTX annual accounts payable has changed by +$1.55M (+38.61%)

What is Edgewise Therapeutics quarterly accounts payable?

The current quarterly accounts payable of EWTX is $8.79M

What is the all time high quarterly accounts payable for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly accounts payable is $8.79M

What is Edgewise Therapeutics quarterly accounts payable year-on-year change?

Over the past year, EWTX quarterly accounts payable has changed by +$4.07M (+86.09%)
On this page